Michael Kiwanuka on the stroke that stopped his tour and the album it shelved

A tour cut short

A year ago, Michael Kiwanuka’s career looked unassailable. His 2024 album Small Changes had drawn critical acclaim and was denied the UK No 1 spot only by Kendrick Lamar’s GNX, no small feat for a genre-blurring singer-songwriter working somewhere between psychedelic rock, prog soul and gospel. A fifth record, Fudge, was lined up for autumn. Then, at the end of July 2025, after a run of European gigs, Kiwanuka returned home to Southampton and, on doctors’ advice, an announcement went out on his Instagram story: the rest of his summer festival dates, including an appearance at Ireland’s All Together Now, and a run of North American shows in October, were off, “due to continued illness”.

That statement, brief and vague by design, is the last thing the public knew until now. In his first interview since, Kiwanuka reveals the illness was a stroke, and that its aftermath has kept him away from his own home in the year since.

What’s confirmed, what’s claimed

The verifiable spine of this story is thin but solid: the cancellation notice was real, dated, and covered at the time by the trade press. Fudge was indeed shelved rather than scrapped. Beyond that, the detail of the stroke, its severity and the specifics of Kiwanuka’s recovery come solely from his own account, given in what is described as his only interview on the subject. That is worth flagging rather than glossing over, a single, controlled interview is not independent medical confirmation, and there is no suggestion here that Kiwanuka or his team owe anyone one. But readers should understand the difference between the hard fact of a cancelled tour and the personal narrative now being placed around it.

The unglamorous arithmetic of falling ill on tour

Strip away the human story for a moment and there’s a familiar industry problem underneath it. An artist mid-campaign, fresh off a near-chart-topping album, geared up for a festival run and a US leg, suddenly can’t perform. Festivals lose a booked act with little notice; promoters, crew and support staff who were contracted around those October shows lose income that doesn’t reappear when a tour is merely postponed rather than rescheduled. None of this is spelled out in what Kiwanuka has said publicly, but it’s the backdrop against which any interrupted campaign like this plays out, and it’s rarely covered with the same interest as the music itself.

There’s also the question of what happens to a record like Fudge, written and recorded before the illness, now arriving into a public conversation reshaped by it. Kiwanuka has spoken of the “poignancy” of finally releasing an album that was meant to land in entirely different circumstances, a poignancy that is genuine, but also, inevitably, part of how the record will now be marketed and received.

The takeaway

What’s certain is that a major British artist’s touring year collapsed abruptly last summer, with real financial and professional consequences that went largely unexplained at the time. What’s newly claimed, the stroke, the inability to return home, the emotional framing of the record’s release, comes from Kiwanuka alone, in a carefully chosen single interview. Both things can be true at once: a serious health event, and a moment now being used, understandably, to reintroduce an album that industry logic had already half-written off.